Granules India Ltd.

₹562.2

-24.5 (-4.2%)

GRANULES Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 13,622 Cr

P/E Ratio27.19

Dividend Yield0.27 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	575.15	Bearish
10-DMA	573.71	Bearish
20-DMA	579.09	Bearish
50-DMA	580.27	Bearish
100-DMA	573.69	Bearish
200-DMA	539.14	Bullish

Historical Performance

1 Year

19.5%

3 Years

98.7%

5 Years

62.4%

10 Years

345.5%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	44,816	45,064	45,119	37,649	32,375
Total Expenditure	35,364	36,504	35,986	30,433	23,823
Other Income	129	44	143	182	269
Operating Profit	9,582	8,604	9,276	7,398	8,821
Interest	1,032	1,058	559	232	263
Depreciation	2,255	2,073	1,845	1,586	1,515
Profit Before Tax	6,602	5,472	6,872	5,580	7,044
Consolidated Net Profit	5,015	4,053	5,166	4,128	5,495
Adjusted EPS	21	17	21	17	22

Compounded Sales Growth

10 Years:28.2

5 Years:11.5

3 Years:3.5

TTM:-0.1

Compounded Profit Growth

10 Years:40.7

5 Years:8.4

3 Years:4

TTM:4.4

Stock Price CAGR

10 Years:16.6

5 Years:10.9

3 Years:25.4

TTM:19.5

Return on Equity

10 Years:5.7

5 Years:22.2

3 Years:21.3

last year:20.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	243	242	242	248	248
Total Reserves	36,776	31,830	27,927	25,450	21,262
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	4,660	1,760	2,547	2,828	3,663
Other Current Liabilities	3,046	2,611	1,932	2,009	1,942
Short Term Borrowings	9,226	10,542	8,109	7,656	4,093
Total Liabilities	61,847	54,839	49,031	45,115	37,127
Capital Work in Progress	4,369	2,595	2,280	3,119	1,848
Long Term Loans & Advances	1,795	1,900	1,575	895	1,256
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	1,802	1,860	1,142	1,304	1,276
Total Current Assets	31,155	29,050	25,742	25,050	19,970
Total Assets	61,847	54,839	49,031	45,115	37,127
Adjusted Book Value	153	132	116	104	87

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 27.19, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 25.4%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹9582 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹44816 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1150634.5

No. of Shares: 2047 (Approx)

Performance:15.1%

P/L: ₹150634.5

NIFTY Performance: 3.4%

1 day Top Gainers